Advertisement
Grab your lab coat. Let's get started
Welcome!
Welcome!
Create an account below to get 6 C&EN articles per month, receive newsletters and more - all free.
It seems this is your first time logging in online. Please enter the following information to continue.
As an ACS member you automatically get access to this site. All we need is few more details to create your reading experience.
Not you? Sign in with a different account.
Not you? Sign in with a different account.
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
December 5, 2005 Cover
Volume 83, Issue 49
Sales grew in the past year, but the pharmaceutical industry saw many major products come under fire and was challenged in moving new ones forward
Credit:
Pharma Reformulates
Sales grew in the past year, but the pharmaceutical industry saw many major products come under fire and was challenged in moving new ones forward
Merck Schedules Big Shake-up
Job cuts and plant closings are among initial steps in restructuring
-
Long Live Riken
At 88, Japan's premier research institute thrives but struggles with global isolation
-
Perkinelmer Hones Life Sciences Plan
With sale of fluid sciences business under way, instrument maker focuses on life sciences
-
Nanotech's Safety Risks
House Science Committee holds hearing to ensure risks of small technology aren't being ignored
